How Retail Pharmacists Can Prepare for the Semglee Biosimilar

Pharmacy Times, Michelle Jesse

Biosimilars have generated buzz since the approval of the first biosimilar in the United States back in 2015. These similar, though not identical, drugs have proven to be as safe and effective as their reference products, allowing the cost effectiveness of biosimilars as a treatment option for patients to increase their ongoing market viability.

For the full article, please visit Pharmacy Times.